Residual Disease in a Novel Xenograft Model of RUNX1-Mutated, Cytogenetically Normal Acute Myeloid Leukemia

Umayal Sivagnanalingam; Marlene Balys; Allison Eberhardt; Nancy Wang; Jason R. Myers; John M. Ashton; Michael W. Becker; Laura M. Calvi; Jason H. Mendler

doi:10.1371/journal.pone.0132375

Loading metrics

Open Access

Peer-reviewed

Research Article

Residual Disease in a Novel Xenograft Model of RUNX1-Mutated, Cytogenetically Normal Acute Myeloid Leukemia

Umayal Sivagnanalingam,

Affiliation Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, United States of America
⨯
Marlene Balys,

Affiliation Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, United States of America
⨯
Allison Eberhardt,

Affiliation Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, United States of America
⨯
Nancy Wang,

Affiliation Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, New York, United States of America
⨯
Jason R. Myers,

Affiliation Genomics Research Center, University of Rochester Medical Center, Rochester, New York, United States of America
⨯
John M. Ashton,

Affiliations Genomics Research Center, University of Rochester Medical Center, Rochester, New York, United States of America, Department of Microbiology & Immunology, James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, United States of America
⨯
Michael W. Becker,

Affiliation Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, United States of America
⨯
Laura M. Calvi,

Affiliation Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, United States of America
⨯
Jason H. Mendler

* E-mail: jason_mendler@urmc.rochester.edu

Affiliation Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, United States of America
⨯

Residual Disease in a Novel Xenograft Model of RUNX1-Mutated, Cytogenetically Normal Acute Myeloid Leukemia

Umayal Sivagnanalingam,
Marlene Balys,
Allison Eberhardt,
Nancy Wang,
Jason R. Myers,
John M. Ashton,
Michael W. Becker,
Laura M. Calvi,
Jason H. Mendler

Published: July 15, 2015
https://doi.org/10.1371/journal.pone.0132375

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Leukemia
Is the Subject Area "Leukemia" applicable to this article?

Thanks for your feedback.
Cancer chemotherapy
Is the Subject Area "Cancer chemotherapy" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Chemotherapy
Is the Subject Area "Chemotherapy" applicable to this article?

Thanks for your feedback.
Acute myeloid leukemia
Is the Subject Area "Acute myeloid leukemia" applicable to this article?

Thanks for your feedback.
Bone marrow cells
Is the Subject Area "Bone marrow cells" applicable to this article?

Thanks for your feedback.
Blood
Is the Subject Area "Blood" applicable to this article?

Thanks for your feedback.
Spleen
Is the Subject Area "Spleen" applicable to this article?

Thanks for your feedback.